Atrial fibrillation risk (4q25)

The 4q25 region near the PITX2 gene is the strongest common genetic signal for atrial fibrillation, an irregular and often rapid heartbeat that can raise stroke risk. The effect is real, but it is one of several factors alongside age and blood pressure.

What the 4q25 locus does

This variant lies in a gene desert on chromosome 4q25, upstream of PITX2, a gene that guides how the left atrium and the sleeves of heart muscle around the pulmonary veins develop. Those sleeves are where most atrial fibrillation starts, as bursts of electrical activity that the atrium cannot organise.

It is the strongest common genetic signal for atrial fibrillation found so far, identified in 2007 and replicated repeatedly since.

How strong the evidence is

The catalogued association reports an odds ratio of 1.72 per risk copy, from a study of 550 cases and 4,476 controls of European ancestry with a p-value below 1e-40. That case count is small by modern standards, and effect sizes from early studies of this size are often somewhat higher than later estimates, so the figure is best read as approximate.

The direction and the locus, however, have held up across many later and much larger studies, including the site's atrial fibrillation polygenic score, where a variant at this same locus carries the largest weight.

An unusually large ancestry difference

In 1000 Genomes reference data, about 26% of East Asian-ancestry individuals carry two risk copies and 49% carry one, against roughly 2% and 23% in European-ancestry samples. That is one of the sharper frequency differences among common disease variants.

Frequency differences between populations do not translate directly into disease-rate differences, since risk depends on many other factors, but they do mean that a percentile or a risk allele count carries different weight depending on the reference group.

What matters more

Age dominates atrial fibrillation. It is uncommon before 50 and common past 75. Beyond age, the strongest contributors are modifiable: high blood pressure, obesity, alcohol including at moderate intake, obstructive sleep apnoea, thyroid overactivity and long-term endurance sport.

Atrial fibrillation is also frequently silent, which is the practical point. Irregular pulses, palpitations, unexplained breathlessness or fatigue are worth mentioning to a doctor, and diagnosis is made on an ECG. Treatment decisions, including anticoagulation to prevent stroke, belong with a clinician.

What each rs2200733 genotype means

rs2200733 has three possible genotypes: CC, CT and TT.

No 4q25 AF variant (rs2200733 CC). You don't carry the 4q25 atrial-fibrillation variant, so as far as this strongest common heart-rhythm gene goes, your risk is at the baseline. Age, blood pressure and overall heart health still matter most.

Higher AF risk (rs2200733 CT). You carry one copy of the 4q25 variant linked to atrial fibrillation (an irregular heartbeat). It raises your risk noticeably for a single common variant, though most carriers never develop it. Worth knowing if you ever feel palpitations, and keeping blood pressure in check helps.

High AF risk (rs2200733 TT). You have two copies of the 4q25 atrial-fibrillation variant, which raises your risk further. This is a tendency, not a certainty: many people with it never develop an irregular heartbeat. If you notice palpitations or have other heart risk factors, it's worth mentioning to a doctor.

Evidence & sources

Across global populations, about 4% of people carry two copies of this variant, and about 67% carry none.

This variant appears in 2 published genetic studies: PubMed 17603472 · PubMed 19597491.

Common questions

Does this variant mean I will develop atrial fibrillation? No. It is the strongest common variant for the condition and still describes a modest shift in odds, on a condition where age, blood pressure, weight and alcohol carry far more of the risk. Most carriers never develop it.

Why is this variant so much more common in East Asian populations? Allele frequencies differ between populations for reasons of population history rather than disease. Around 26% of East Asian-ancestry individuals in reference data carry two copies against about 2% of European-ancestry individuals, which does not by itself mean the condition is proportionally more common.

Related

Age-related macular degeneration · APOE type (Alzheimer's & cholesterol) · Autoimmune risk (PTPN22 R620W) · Diastolic blood pressure · Longevity-associated variant (FOXO3) · Rheumatoid arthritis · Type 2 diabetes protection (PPARG Pro12Ala)